Vivus

Orexigen asks FDA for weight-loss drug approval
Yahoo/AP
Wed, 03/31/10 - 09:51 pm
Orexigen
FDA
obesity
Contrave
Vivus
Arena Pharmaceuticals
Qnexa
Vivus ends development agreement with FemPharm
Yahoo/AP
Wed, 03/31/10 - 09:36 am
Vivus
FemPharm
testosterone
FDA to Review VIVUS Drug
Yahoo/Zacks.com
Mon, 03/29/10 - 11:23 am
FDA
obesity
Vivus
Orexigen
Arena Pharmaceuticals
Qnexa
Amylin
Bulls Anticipating a Vivus Upside
Seeking Alpha
Sat, 03/27/10 - 11:15 am
Vivus
obesity
Qnexa
FDA panel to review Vivus drug in July
Fierce Biotech
Fri, 03/26/10 - 09:09 am
Vivus
FDA
obesity
Qnexa
What to Expect for Biotech Stocks
Minyanville
Fri, 03/19/10 - 09:03 am
biotech
Cell Therapeutics
Somaxon
Dendreon
Allos
GenVec
Arena Pharmaceuticals
Vivus
3 Ways to Play the Obesity Drugs
TheStreet.com
Tue, 03/16/10 - 10:05 am
obesity
Arena Pharmaceuticals
Vivus
Orexigen
Contrave
Qnexa
lorcaserin
Vivus Q4 loss nearly doubles to $13.2M
Bizjournals.com
Mon, 03/8/10 - 07:17 pm
earnings
Vivus
FDA accepts Vivus application for obesity drug
Marketwatch
Mon, 03/1/10 - 09:57 am
FDA
Vivus
obesity
Qnexa
Biotech Stock Mailbag: NexMed
TheStreet.com
Fri, 02/12/10 - 08:20 am
NexMed
Sequenom
Vivus
Keryx
Targacept
Immunogen
Cell Therapeutics
2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters
BNET Pharma
Tue, 02/9/10 - 11:14 am
FDA
Cadence Pharmaceuticals
Acorda Therapeutics
Auxilium
Gilead Sciences
Shire
Amylin
Cell Therapeutics
Dendreon
InterMune
Amgen
Human Genome
NicOx
Vivus
Arena Pharmaceuticals
Orexigen
Five Drugs To Watch (Assuming FDA Approval)
Pharmalot
Mon, 02/1/10 - 10:08 am
FDA
Dendreon
Provenge
Victoza
Novo Nordisk
Qnexa
Vivus
Prolia
Amgen
Bayer
JNJ
Xarelto
Investors betting heavily on Vivus obesity drug
Marketwatch
Thu, 01/21/10 - 07:49 am
Vivus
obesity
Qnexa
Vivus reports positive data on ED drug candidate
Yahoo/AP
Mon, 01/11/10 - 11:28 am
Vivus
erectile dysfunction
Avanafil
Drug stocks rise; MAP and Vivus gain on drug updates
Marketwatch
Mon, 01/11/10 - 11:12 am
Vivus
drug stocks
MAP Pharmaceuticals
Biotech Drugs to Watch In 2010
Minyanville
Thu, 01/7/10 - 11:15 am
Arena Pharmaceuticals
Vivus
Orexigen
Novo Nordisk
Amylin
Eli Lilly
Biogen Idec
Acorda Therapeutics
Dendreon
MannKind
Vivus says mid-stage study shows its obesity drug candidate Qnexa reduced sleep apnea symptoms
Yahoo/AP
Thu, 01/7/10 - 11:10 am
Vivus
Qnexa
sleep apnea
2010 FDA Decisions to Watch
Motley Fool
Sun, 01/3/10 - 11:41 am
FDA
Pfizer
Nektar
MannKind
Afresa
Eli Lilly
Amylin
Dendreon
Vivus
Alkermes
Arena Pharmaceuticals
Orexigen
Vivus files application with FDA for obesity drug
Marketwatch
Tue, 12/29/09 - 09:14 am
FDA
Vivus
obesity
Qnexa
Biotech Calendar: Upcoming FDA Dates
TheStreet.com
Tue, 12/15/09 - 08:56 am
FDA
Dendreon
Arena Pharmaceuticals
Chelsea Therapeutics
Cephalon
Biodel
Auxilium
Novartis
Novo Nordisk
Shire
Vivus
MannKind
Acorda Therapeutics

Pages